Sort by:

select Language:



Landscape for HIV rapid diagnostic tests for HIV self-testing

World Health Organization WHO; UNITAID, (2018)


This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United Nation’s 90-90-90 targets. In particular, the report synthesises the existing and emerging market demand and supply of kits. The information in this report is intended for manufacturers, donors, national programmes, researchers and other global health stakeholders who are exploring the potential role of HIVST.
https://unitaid.org/assets/HIVST-landscape-report....


Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs round 8 (2016-2018). Summary

World Health Organization WHO; FIND; CDC, (2018)


This report, published in conjunction with a summary overview of results of rounds 1–8, is the eighth and final report in a series of laboratory-based evaluations of rapid diagnostic tests (RDTs) for malaria. It provides a comparative measure of their performance in a standardized way to distinguish between well and poorly performing tests. These results constitute the laboratory evaluation component of the WHO prequalification process for malaria RDTs and inform the current WHO procurement recommendations. In round 8, 35 RDTs from 17 manufacturers were assessed. For the first time the evaluation included an assessment of product performance against a panel of P. falciparum parasites with pfhrp2/3 gene deletions and therefore not expressing HRP2.
https://apps.who.int/iris/bitstream/handle/10665/2...


Guidelines for malaria vector control

World Health Organization WHO, (2019)


The Guidelines for malaria vector control provide a “one-stop shop” for all countries and partners working to implement effective malaria vector control measures. They cover the 2 core malaria vector control interventions – ITNs and IRS – as well as supplementary interventions, namely chemical and biological larvicides, and personal protection measures, such as the use of topical repellents. The guidelines consolidate more than 20 sets of WHO recommendations and good practice statements in one user-friendly format.
https://apps.who.int/iris/bitstream/handle/10665/3...


Latent TB Infection : Updated and consolidated guidelines for programmatic management

World Health Organization WHO, (2018)


The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants. The guidelines are to be used primarily in national TB and HIV control programmes, or their equivalents in ministries of health, and for other policy-makers working on TB and HIV and infectious diseases. They are also appropriate for officials in other line ministries with work in the areas of health.
http://apps.who.int/iris/bitstream/10665/260233/1/...


Интеграция профилактики, лечения и ведения психических расстройств и других неинфекционных заболеваний в системе здравоохранения

World Health Organization WHO, (2019)


Психические расстройства имеют общие черты с другими неинфекционными заболеваниями, в том числе многие основные причины и общие последствия, высокую степень взаимозависимости и склонность развиваться одновременно, а также то, что их наиболее эффективное лечению связано с использованием интегрированных подходов. Схемы более интегрированного планирования и программирования включают: вмешательства популяционного уровня, направленные на повышение осведомленности о факторах риска НИЗ и психических расстройств и их снижение (посредством изменения законодательства, регулирования и повышения информированости); внедрение программ, осуществляемых в школах, на рабочих местах и в сообществах в целях укрепления психического и физического благополучия; предоставление более индивидуальных услуг здравоохранения, и предоставление более координированной помощи людям с (часто коморбидными) психическими и соматическими заболеваниями.
http://www.euro.who.int/__data/assets/pdf_file/000...


Guidelines for the Diagnosis, Treatment and Prevention of Leprosy

World Health Organization WHO, (2018)


The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infectious diseases in the ministries of health (‎especially but not limited to endemic countries)‎, nongovernmental organizations, clinicians, pharmaceutical companies, donors and affected persons
http://apps.who.int/iris/handle/10665/274127


Global guidelines on the prevention of surgical site infection. 2nd edition

World Health Organization WHO, (2018)


These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences. The 2018 edition of the guidelines includes the revision of the recommendation regarding the use of 80% fraction of inspired oxygen (high FiO2) in surgical patients under general anaesthesia with tracheal intubation and the update of the section on implementation. Between 2017 and 2018, WHO re-assessed the evidence on the use of high FiO2 by updating the systematic review related to the effectiveness of this intervention to reduce SSI and commissioning an independent systematic review on adverse events potentially associated with it. Based on the updated evidence, the GDG decided to revise the strength of the recommendation from strong to conditional.
https://apps.who.int/iris/bitstream/handle/10665/2...


824 hits